Publications<< Back

Bravo Y, Martí-Fàbregas J, Cocho D, Rodríguez-Yáñez M, Castellanos M, de la Ossa NP, Roquer J, Obach V, Maestre J, Martí-Vilalta JL

Influence of antiplatelet pre-treatment on the risk of symptomatic intracranial haemorrhage after intravenous thrombolysis.

Cerebrovasc. Dis.. 2008;26(2):126-33, PMID: 18560215

The influence of antiplatelet agents (AP) in the development of a symptomatic intracranial haemorrhage (SICH) after intravenous rt-PA is not well known. We assessed the hypothesis that pre-treatment with AP may increase that risk.

CLINICAL NEUROLOGY